Cannara Biotech Inc. (TSXV: LOVE)

Cannara Biotech Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	6.62	6.62	4.27	12.11	8.16	7.77
Cash & Short-Term Investments	6.62	6.62	4.27	12.11	8.16	7.77
Cash Growth	55.03%	55.03%	-64.75%	48.48%	4.99%	-70.68%
Accounts Receivable	13.04	13.04	10.59	8.62	2.92	0.06
Other Receivables	-	-	-	-	0.05	0.25
Receivables	13.04	13.04	10.59	8.62	2.97	0.31
Inventory	40.07	40.07	33.77	18.98	7.41	2.24
Prepaid Expenses	2.85	2.85	3.06	1.28	0.71	0.21
Other Current Assets	4.9	4.9	-	-	-	-
Total Current Assets	67.47	67.47	51.7	40.99	19.25	10.53
Property, Plant & Equipment	84.94	84.94	89.44	83.4	71.75	43.64
Other Intangible Assets	-	-	-	-	-	0.16
Long-Term Accounts Receivable	-	-	-	-	0.07	0.07
Long-Term Deferred Tax Assets	1.95	1.95	-	-	-	-
Long-Term Deferred Charges	-	-	0.06	-	-	-
Other Long-Term Assets	0.36	0.36	0.33	1.22	0.95	0.44
Total Assets	154.72	154.72	141.52	125.62	92.02	54.85
Accounts Payable	9.5	9.5	8.12	8.85	6.19	2.76
Accrued Expenses	7.86	7.86	6.86	0.77	0.07	0.16
Short-Term Debt	6.26	6.26	3	-	-	-
Current Portion of Long-Term Debt	2.97	2.97	2.97	1.97	0.3	0.3
Current Portion of Leases	0.28	0.28	0.08	0.22	0.23	0.21
Current Unearned Revenue	0.13	0.13	0.16	0.05	0.04	0.05
Total Current Liabilities	27	27	21.18	11.86	6.83	3.48
Long-Term Debt	38.45	38.45	39.64	46.19	20.15	11.98
Long-Term Leases	0.37	0.37	0.1	0.02	0.22	0.44
Long-Term Unearned Revenue	0.94	0.94	0.86	0.82	0.71	0.51
Other Long-Term Liabilities	-	-	-	-	-	0.08
Total Liabilities	66.77	66.77	61.78	58.88	27.91	16.49
Common Stock	88.52	88.52	88.8	83.3	83.21	58.36
Additional Paid-In Capital	12.33	12.33	10.35	9.72	9.41	7.03
Retained Earnings	-12.9	-12.9	-19.34	-26.3	-28.61	-27.08
Comprehensive Income & Other	-	-	-0.07	0.02	0.1	0.05
Total Common Equity	87.95	87.95	79.74	66.74	64.12	38.36
Shareholders' Equity	87.95	87.95	79.74	66.74	64.12	38.36
Total Liabilities & Equity	154.72	154.72	141.52	125.62	92.02	54.85
Total Debt	48.33	48.33	45.78	48.39	20.9	12.94
Net Cash (Debt)	-41.71	-41.71	-41.51	-36.28	-12.74	-5.16
Net Cash Per Share	-0.46	-0.46	-0.46	-0.41	-0.17	-0.07
Filing Date Shares Outstanding	90.02	90.02	90.02	87.7	87.65	73.78
Total Common Shares Outstanding	90.02	90.02	90.31	87.7	87.65	73.77
Working Capital	40.47	40.47	30.51	29.13	12.41	7.05
Book Value Per Share	0.98	0.98	0.88	0.76	0.73	0.52
Tangible Book Value	87.95	87.95	79.74	66.74	64.12	38.2
Tangible Book Value Per Share	0.98	0.98	0.88	0.76	0.73	0.52
Land	2.33	2.33	2.45	2.45	2.45	1.1
Buildings	76.71	76.71	75.48	64.3	44.79	37.63
Machinery	20.65	20.65	18.57	14.22	8.47	7.2
Construction In Progress	4.71	4.71	6.73	11.53	21.23	-

Source: S&P Capital IQ. Standard template. Financial Sources.